LCM-1910

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLCM-1910
Drug Alias NameRGD-derivativeLCM-1910
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsCataract
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratoire Chauvin Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratoire Chauvin Sas
Active IndicationsN/A
Inactive IndicationsCataract

Other Information

ATC CodeN/A
Related LinksN/A